Kamil W Nowicki1, Koji Hosaka2, Frank J Walch3, Edward W Scott4, Brian L Hoh2. 1. Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. 2. Department of Neurosurgery, University of Florida, Gainesville, Florida, USA. 3. Department of Neurosurgery, University of Colorado, Denver, Colorado, USA. 4. Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA.
Abstract
INTRODUCTION: Macrophages and neutrophils have been separately implicated in cerebral aneurysm formation. The interactions between different myeloid subsets and the contributions of macrophage phenotypes in these lesions over time are not known. The purpose of the study was to examine macrophage phenotypic changes in cerebral aneurysms. METHODS: We induced aneurysm formation in C57BL/6 mice and quantified contributions of M1 and M2 macrophages in aneurysm specimens with or without neutrophil blockade. In our aneurysm model, the left common carotid and right renal arteries were ligated, and mice were placed on a hypertensive high fat diet. One week later, stereotactic injection with elastase solution into the basal cisterns was performed. An angiotensin II secreting osmotic pump was implanted. The mice were then treated with anti-CXCL1 antibody or IgG control antibody. Animals were euthanized at 3 days, or 1 or 2 weeks. The circle of Willis was analyzed using immunohistochemistry for M1 and M2 macrophage phenotype contributions. RESULTS: Proinflammatory M1/M2 ratio increased in cerebral aneurysm formation over time, from 0.56 at 3 days to 1.75 at 2 weeks (p<0.0001). In contrast, anti-CXCL1 antibody blockade led to polarization towards an anti-inflammatory phenotype with an M1/M2 ratio of 0.95 at 2 weeks compared with IgG treated mice (p=0.0007). CONCLUSIONS: CXCL1 dependent neutrophil inflammation appears to have an important role in macrophage polarization to M1 phenotype in cerebral aneurysm development. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
INTRODUCTION: Macrophages and neutrophils have been separately implicated in cerebral aneurysm formation. The interactions between different myeloid subsets and the contributions of macrophage phenotypes in these lesions over time are not known. The purpose of the study was to examine macrophage phenotypic changes in cerebral aneurysms. METHODS: We induced aneurysm formation in C57BL/6 mice and quantified contributions of M1 and M2 macrophages in aneurysm specimens with or without neutrophil blockade. In our aneurysm model, the left common carotid and right renal arteries were ligated, and mice were placed on a hypertensive high fat diet. One week later, stereotactic injection with elastase solution into the basal cisterns was performed. An angiotensin II secreting osmotic pump was implanted. The mice were then treated with anti-CXCL1 antibody or IgG control antibody. Animals were euthanized at 3 days, or 1 or 2 weeks. The circle of Willis was analyzed using immunohistochemistry for M1 and M2 macrophage phenotype contributions. RESULTS: Proinflammatory M1/M2 ratio increased in cerebral aneurysm formation over time, from 0.56 at 3 days to 1.75 at 2 weeks (p<0.0001). In contrast, anti-CXCL1 antibody blockade led to polarization towards an anti-inflammatory phenotype with an M1/M2 ratio of 0.95 at 2 weeks compared with IgG treated mice (p=0.0007). CONCLUSIONS:CXCL1 dependent neutrophil inflammation appears to have an important role in macrophage polarization to M1 phenotype in cerebral aneurysm development. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Yasuhisa Kanematsu; Miyuki Kanematsu; Chie Kurihara; Yoshiteru Tada; Tsung-Ling Tsou; Nico van Rooijen; Michael T Lawton; William L Young; Elena I Liang; Yoshitsugu Nuki; Tomoki Hashimoto Journal: Stroke Date: 2010-11-24 Impact factor: 7.914
Authors: David M Hasan; Kelly B Mahaney; Vincent A Magnotta; David K Kung; Michael T Lawton; Tomoki Hashimoto; H Richard Winn; David Saloner; Alastair Martin; Seymur Gahramanov; Edit Dósa; Edward Neuwelt; William L Young Journal: Arterioscler Thromb Vasc Biol Date: 2012-02-09 Impact factor: 8.311
Authors: Anjali Chauhan; Abdullah Al Mamun; Gabriel Spiegel; Nia Harris; Liang Zhu; Louise D McCullough Journal: Neurobiol Aging Date: 2017-09-28 Impact factor: 4.673
Authors: Vincent M Tutino; Hamidreza Rajabzadeh-Oghaz; Sricharan S Veeturi; Kerry E Poppenberg; Muhammad Waqas; Max Mandelbaum; Nicholas Liaw; Adnan H Siddiqui; Hui Meng; John Kolega Journal: Neurosurg Rev Date: 2021-01-26 Impact factor: 2.800
Authors: Kerry E Poppenberg; Lu Li; Muhammad Waqas; Nikhil Paliwal; Kaiyu Jiang; James N Jarvis; Yijun Sun; Kenneth V Snyder; Elad I Levy; Adnan H Siddiqui; John Kolega; Hui Meng; Vincent M Tutino Journal: PLoS One Date: 2020-11-06 Impact factor: 3.240